{"id":"aur101","safety":{"commonSideEffects":[{"rate":"40-50%","effect":"Neutropenia"},{"rate":"30-40%","effect":"Thrombocytopenia"},{"rate":"20-30%","effect":"Anemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BTK is a key component of the B cell receptor signaling complex and plays a crucial role in the development and maintenance of B cell malignancies. Inhibiting BTK has been shown to be effective in treating various B cell cancers.","oneSentence":"AUR101 is a small molecule inhibitor of the Bruton's tyrosine kinase (BTK) enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:29:46.672Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Relapsed or refractory mantle cell lymphoma"},{"name":"Relapsed or refractory marginal zone lymphoma"}]},"trialDetails":[{"nctId":"NCT04207801","phase":"PHASE2","title":"A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis","status":"COMPLETED","sponsor":"Aurigene Discovery Technologies Limited","startDate":"2020-01-21","conditions":"Chronic Plaque-type Psoriasis","enrollment":90},{"nctId":"NCT04855721","phase":"PHASE2","title":"A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)","status":"COMPLETED","sponsor":"Aurigene Discovery Technologies Limited","startDate":"2021-05-04","conditions":"Plaque Psoriasis","enrollment":141}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["No other names"],"phase":"phase_2","status":"active","brandName":"AUR101","genericName":"AUR101","companyName":"Aurigene Discovery Technologies Limited","companyId":"aurigene-discovery-technologies-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AUR101 is a small molecule inhibitor of the Bruton's tyrosine kinase (BTK) enzyme. Used for Relapsed or refractory mantle cell lymphoma, Relapsed or refractory marginal zone lymphoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}